Editorial: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer Therapy

Curr Cancer Drug Targets. 2016;16(2):100. doi: 10.2174/156800961602160105154407.

Author

Masatoshi Kitagawa¹

Affiliation

¹ Department of Molecular Biology Hamamatsu University School of Medicine Hamamatsu Japan. kitamasa@hama-med.ac.jp.

PMID: 26791134
DOI: 10.2174/156800961602160105154407

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Antineoplastic Agents / chemistry
Antineoplastic Agents / therapeutic use*
Drug Design
Drug Discovery / methods*
Enzyme Inhibitors / chemistry
Enzyme Inhibitors / therapeutic use*
Humans
Molecular Targeted Therapy*
Neoplasms / drug therapy*
Neoplasms / enzymology
Neoplasms / genetics
Neoplasms / pathology
RNAi Therapeutics
Signal Transduction / drug effects
Ubiquitin-Protein Ligases / antagonists & inhibitors*
Ubiquitin-Protein Ligases / genetics
Ubiquitin-Protein Ligases / metabolism

Substances

Antineoplastic Agents
Enzyme Inhibitors
Ubiquitin-Protein Ligases